Company / Operating Margin
Stoke Therapeutics, Inc. Operating Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-11.2%
FY2025
5-year range
-1307.2% / -11.2%
FY2022-FY2025
Trend
+99.1%
vs FY2024
Sector context
#60 of 136
Health Care
What the data says
At -11.2%, Stoke Therapeutics, Inc.'s operating margin ranks #60 of 136 in the Health Care sector. Operating Margin returned to growth in FY2025 after 2 years of decline, reaching -11.2%.
Based on SEC 10-K filings.
-11.2% in FY2025 with a 3-year CAGR of +682.6%.
Improved from -841.2% to -11.2% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +682.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#60 of 136 in Health CareTop 44% of 136This company -11.2% Sector average -778.9%
▼
+98.6% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 99.1% year-over-year.
- Currently 767.8pp above the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -11.2% | +99.1% |
| FY2024 | -1307.2% | -55.4% |
| FY2023 | -841.2% | -21.3% |
| FY2022 | -693.8% | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026